SERINC2 and thyroid tumor: In summary, our work shows a preliminary integrated analysis of the methylome and transcriptome in PTC, and a novel perspective for SERINC2 as a potential biomarker to tell indolent thyroid tumors from more aggressive thyroid cancer.